{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T22:45:18Z","timestamp":1775947518158,"version":"3.50.1"},"reference-count":30,"publisher":"Japan Atherosclerosis Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2019,10,1]]},"DOI":"10.5551\/jat.47399","type":"journal-article","created":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T22:30:59Z","timestamp":1551738659000},"page":"847-855","source":"Crossref","is-referenced-by-count":12,"title":["One-Year Clinical Outcomes following Implantation of Innova<sup>TM<\/sup> Self-Expanding Nitinol Stents in Patients with Peripheral Artery Diseases Presenting Femoropopliteal Artery Lesions"],"prefix":"10.5551","volume":"26","author":[{"given":"Takuya","family":"Tsujimura","sequence":"first","affiliation":[{"name":"Cardiovascular Center, Kansai Rosai Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuyoshi","family":"Takahara","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Iida","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Kansai Rosai Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichi","family":"Hiramori","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kokura Memorial Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Hayakawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Asahi General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Karashima","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shimonoseki Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Miura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Shinshu University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Teramura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Ichinomiya Nishi Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Ichihashi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Ichinomiya Nishi Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tai","family":"Kojima","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Gifu Prefectural General Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Aihara","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tsukuba Medical Center Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terutoshi","family":"Yamaoka","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Matsuyama Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Fujihara","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kishiwada Tokushukai Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Tosaka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kawakita General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuki","family":"Doijiri","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Yamato Seiwa Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Mano","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Kansai Rosai Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimitsu","family":"Soga","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kokura Memorial Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Aboyans V, Ricco JB, Bartelink MEL, Bj\u00f6rck M, Brodmann M, Cohnert T, Collet JP, Czerny M, De Carlo M, Debus S, Espinola-Klein C, Kahan T, Kownator S, Mazzolai L, Naylor AR, Roffi M, R\u00f6ther J, Sprynger M, Tendera M, Tepe G, Venermo M, Vlachopoulos C, Desormais I. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J, 2018; 39: 763-816","DOI":"10.1093\/eurheartj\/ehx095"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FG, Hamburg NM, Kinlay S, Lookstein R, Misra S, Mureebe L, Olin JW, Patel RA, Regensteiner JG, Schanzer A, Shishehbor MH, Stewart KJ, Treat-Jacobson D, Walsh ME. 2016 AHA\/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol, 2017; 69: 1465-1508","DOI":"10.1016\/j.jacc.2016.11.008"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Conte MS, Pomposelli FB, Clair DG, Geraghty PJ, McKinsey JF, Mills JL, Moneta GL, Murad MH, Powell RJ, Reed AB, Schanzer A, Sidawy AN. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and claudication. J Vasc Surg, 2015; 61: 2S-41S","DOI":"10.1016\/j.jvs.2014.12.009"},{"key":"4","unstructured":"4) Dormandy JA, Rutherford B. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg, 2000; 31: S1-S296"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Johnston KW. Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. Radiology, 1992; 183: 767-771","DOI":"10.1148\/radiology.183.3.1294068"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Minar E, Pokrajac B, Maca T, Ahmadi R, Fellner C, Mittlb\u00f6ck M, Seitz W, Wolfram R, P\u00f6tter R. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: results of a prospective randomized study. Circulation, 2000; 102: 2694-2699","DOI":"10.1161\/01.CIR.102.22.2694"},{"key":"7","unstructured":"7) Capek P, McLean GK, Berkowitz HD. Femoropopliteal angioplasty: factors influencing long-term success. Circulation, 1991; 83: Suppl 2: 170-180"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, Schlager O, Cejna M, Lammer J, Minar E. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med, 2006; 354: 1879-1888","DOI":"10.1056\/NEJMoa051303"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Sabeti S, Schillinger M, Amighi J, Sherif C, Mlekusch W, Ahmadi R, Minar E. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel selfexpanding stents: propensity score-adjusted analysis. Radiology, 2004; 232: 516-521","DOI":"10.1148\/radiol.2322031345"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, Dave R, Ansel G, Lansky A, Cristea E, Collins TJ, Goldstein J, Jaff MR. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: Twelvemonth results from the RESILIENT randomized trial. Circ Cardiovasc Interv, 2010; 3: 267-276","DOI":"10.1161\/CIRCINTERVENTIONS.109.903468"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Powell RJ, Jaff MR, Schro\u00eb H, Benko A, Diaz-Cartelle J, M\u00fcller-H\u00fclsbeck S. Stent placement in the superficial femoral and proximal popliteal arteries with the innova self-expanding bare metal stent system. Catheter Cardiovasc Interv, 2017; 89: 1069-1077","DOI":"10.1002\/ccd.26976"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Tosaka A, Soga Y, Iida O, Ishihara T, Hirano K, Suzuki K, Yokoi H, Nanto S, Nobuyoshi M. Classification and clin ical impact of restenosis after femoropopliteal stenting. J Am Coll Cardiol, 2012; 59: 16-23","DOI":"10.1016\/j.jacc.2011.09.036"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Soga Y, Iida O, Hirano K, Yokoi H, Nanto S, Nobuyoshi M.J. Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent. J Vasc Surg, 2010; 52: 608-615","DOI":"10.1016\/j.jvs.2010.03.050"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Okuno S, Iida O, Shiraki T, Fujita M, Masuda M, Okamoto S, Ishihara T, Nanto K, Kanda T, Takahara M, Uematsu M. Impact of Calcification on Clinical Outcomes After Endovascular Therapy for Superficial Femoral Artery Disease: Assessment Using the Peripheral Artery Calcification Scoring System. J Endovasc Ther, 2016; 23: 731-737","DOI":"10.1177\/1526602816656612"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Iida O, Soga Y, Hirano K, Suzuki K, Yokoi H, Nobuyoshi M, Muramatsu T, Inoue N, Nanto S, Uematsu M. Longterm outcomes and risk stratification of patency following nitinol stenting in the femoropopliteal segment: retrospective multicenter analysis. J Endovasc Ther, 2011; 18: 753-761","DOI":"10.1583\/11-3581.1"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Suzuki K, Iida O, Soga Y, Hirano K, Inoue N, Uematsu M, Yokoi H, Muramatsu T, Nanto S, Nobuyoshi M, Meguro T. Long-term results of the S.M.A.R.T. Control(TM) stent for superficial femoral artery lesions, J-SMART registry. Circ J, 2011; 75: 939-944","DOI":"10.1253\/circj.CJ-10-1029"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Gray WA, Feiring A, Cioppi M, Hibbard R, Gray B, Khatib Y, Jessup D, Bachinsky W, Rivera E, Tauth J, Patarca R, Massaro J, Stoll HP, Jaff MR; STROLL Study Investigators. S.M.A.R.T. self-expanding nitinol stent for the treatment of atherosclerotic lesions in the superficial femoral artery (STROLL): 1-year outcomes. J Vasc Interv Radiol, 2015; 26: 21-28","DOI":"10.1016\/j.jvir.2014.09.018"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Iida O, Soga Y, Hirano K, Okamoto S, Dohi T, Uematsu M, Yokoi H, Nobuyoshi M, Muramatsu T, Fujita M, Nanto S, Nagata S. Retrospective multicentre analysis of S.M.A.R.T. vs. Luminexx nitinol stent implantation for superficial femoral artery lesions (REAL SL) Registry. 5 years\u2019 experience. Circ J, 2011; 75: 421-427","DOI":"10.1253\/circj.CJ-10-0741"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Schulte KL, Kralj I, Gissler HM, Bagnaschino LA, Buschmann I, Pern\u00e8s JM, Haage P, Goverde P, Beregi JP, V\u00e1lka M, Boudny J, Geibel T, Velkoborsky M, Z\u00e4hringer M, Paetzel C, Fanelli F, M\u00fcller-H\u00fclsbeck S, Zeller T, Langhoff R. MISAGO 2: one-year outcomes after implantation of the Misago self-expanding nitinol stent in the superficial femoral and popliteal arteries of 744 patients. J Endovasc Ther, 2012; 19: 774-784","DOI":"10.1583\/JEVT-12-3861MR.1"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Ohki T, Angle JF, Yokoi H, Jaff MR, Popma J, Piegari G, Kanaoka Y; OSPREY investigators. One-year outcomes of the U.S. and Japanese regulatory trial of the Misago stent for treatment of superficial femoral artery disease (OSPREY study). J Vasc Surg, 2016; 63: 370-376","DOI":"10.1016\/j.jvs.2015.08.093"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, Dave R, Ansel G, Lansky A, Cristea E, Collins TJ, Goldstein J, Jaff MR; RESILIENT Investigators. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: Twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv, 2010; 3: 267-276","DOI":"10.1161\/CIRCINTERVENTIONS.109.903468"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg, 2007; 45: S5-67","DOI":"10.1016\/j.jvs.2006.12.037"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Abularrage CJ, Conrad MF, Hackney LA, Paruchuri V, Crawford RS, Kwolek CJ, LaMuraglia GM, Cambria RP. Long-term outcomes of diabetic patients undergoing endovascular infrainguinal interventions. J Vasc Surg, 2010; 52: 314-322","DOI":"10.1016\/j.jvs.2010.03.015"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Iida O, Uematsu M, Soga Y, Hirano K, Suzuki K, Yokoi H, Muramatsu T, Inoue N, Nanto S, Nagata S. Timing of the restenosis following nitinol stenting in the superficial femoral artery and the factors associated with early and late restenoses. Catheter Cardiovasc Interv, 2011; 78: 611-617","DOI":"10.1002\/ccd.23064"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Hiramori S, Soga Y, Iida O, Suzuki K, Hirano K, Kawasaki D, Shintani Y, Ando K. Relationship between clinical outcomes and vessel size in endovascular therapy for femoropopliteal lesions. J Vasc Surg, 2017; 65: 1690-1697","DOI":"10.1016\/j.jvs.2016.12.128"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, Dave R, Ansel G, Lansky A, Cristea E, Collins TJ, Goldstein J, Jaff MR; RESILIENT Investigators. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv, 2010; 3: 267-276","DOI":"10.1161\/CIRCINTERVENTIONS.109.903468"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Iida O, Yokoi H, Soga Y, Inoue N, Suzuki K, Yokoi Y, Kawasaki D, Zen K, Urasawa K, Shintani Y, Miyamoto A, Hirano K, Miyashita Y, Tsuchiya T, Shinozaki N, Nakamura M, Isshiki T, Hamasaki T, Nanto S; STOP-IC investigators. Cilostazol reduces angiographic restenosis after endovascular therapy for femoropopliteal lesions in the Sufficient Treatment of Peripheral Intervention by Cilostazol study. Circulation, 2013; 127: 2307-2315","DOI":"10.1161\/CIRCULATIONAHA.112.000711"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Zen K, Takahara M, Iida O, Soga Y, Kawasaki D, Nanto S, Yokoi H, Matoba S; ZEPHYR Investigators. Drugeluting stenting for femoropopliteal lesions, followed by cilostazol treatment, reduces stent restenosis in patients with symptomatic peripheral artery disease. J Vasc Surg, 2017; 65: 720-725","DOI":"10.1016\/j.jvs.2016.10.098"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Benjo AM, Garcia DC, Jenkins JS, Cardoso RM, Molina TP, El-Hayek GE, Nadkarni GN, Aziz EF, Dinicolantonio JJ, Collins T. Cilostazol increases patency and reduces adverse outcomes in percutaneous femoropopliteal revascularisation: a meta-analysis of randomised controlled trials. Open Heart, 2014; 1: e000154","DOI":"10.1136\/openhrt-2014-000154"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Soga Y, Hamasaki T, Edahiro R, Iida O, Inoue N, Suzuki K, Yokoi Y, Kawasaki D, Zen K, Urasawa K, Aodo K; STOP-IC investigators. Sustained effectiveness of cilostazol after endovascular treatment of femoropopliteal lesions: midterm follow-up from the sufficient treatment of peripheral intervention by cilostazol (STOP-IC) study. J Endovasc Ther, 2018; 25: 306-312","DOI":"10.1177\/1526602818771358"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/26\/10\/26_47399\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T03:45:01Z","timestamp":1570247101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/26\/10\/26_47399\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,1]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.47399","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,1]]}}}